96 related articles for article (PubMed ID: 26526970)
1. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970
[TBL] [Abstract][Full Text] [Related]
2. Dual targetable drug delivery system based on cell membrane camouflaged liposome for enhanced tumor targeting and improved anti-tumor efficiency.
Duan M; Zhou D; Ke J; Chen Y; Wu W; Li Y; Ren J; Wang L; Zhang Z; Wang C
Colloids Surf B Biointerfaces; 2024 Jun; 238():113892. PubMed ID: 38581834
[TBL] [Abstract][Full Text] [Related]
3. Enhanced active targeting via cooperative binding of ligands on liposomes to target receptors.
Sugiyama T; Asai T; Nedachi YM; Katanasaka Y; Shimizu K; Maeda N; Oku N
PLoS One; 2013; 8(6):e67550. PubMed ID: 23840738
[TBL] [Abstract][Full Text] [Related]
4. EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer.
Moles E; Chang DW; Mansfeld FM; Duly A; Kimpton K; Logan A; Howard CB; Thurecht KJ; Kavallaris M
Int J Nanomedicine; 2024; 19():3623-3639. PubMed ID: 38660023
[TBL] [Abstract][Full Text] [Related]
5. Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
Wang Y; Shi K; Zhang L; Hu G; Wan J; Tang J; Yin S; Duan J; Qin M; Wang N; Xie D; Gao X; Gao H; Zhang Z; He Q
Autophagy; 2016 Jun; 12(6):949-62. PubMed ID: 27123811
[TBL] [Abstract][Full Text] [Related]
6. Albumin Nanoparticles Increase the Efficacy of Doxorubicin Hydrochloride Liposome Injection Based on Threshold Theory.
Lin W; Li A; Qiu L; Huang H; Cui P; Wang J
Mol Pharm; 2024 Jun; 21(6):2970-2980. PubMed ID: 38742943
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma.
Omstead DT; Mejia F; Sjoerdsma J; Kim B; Shin J; Khan S; Wu J; Kiziltepe T; Littlepage LE; Bilgicer B
J Hematol Oncol; 2020 Nov; 13(1):145. PubMed ID: 33138841
[TBL] [Abstract][Full Text] [Related]
8. Perfusion-guided sonopermeation of neuroblastoma: a novel strategy for monitoring and predicting liposomal doxorubicin uptake
Bellary A; Villarreal A; Eslami R; Undseth QJ; Lec B; Defnet AM; Bagrodia N; Kandel JJ; Borden MA; Shaikh S; Chopra R; Laetsch TW; Delaney LJ; Shaw CM; Eisenbrey JR; Hernandez SL; Sirsi SR
Theranostics; 2020; 10(18):8143-8161. PubMed ID: 32724463
[TBL] [Abstract][Full Text] [Related]
9. Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan.
Kohli AG; Kivimäe S; Tiffany MR; Szoka FC
J Control Release; 2014 Oct; 191():105-14. PubMed ID: 24852095
[TBL] [Abstract][Full Text] [Related]
10. Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.
Garg A; Tisdale AW; Haidari E; Kokkoli E
Int J Pharm; 2009 Jan; 366(1-2):201-10. PubMed ID: 18835580
[TBL] [Abstract][Full Text] [Related]
11. Tracking Drugs and Lipids: Quantitative Mass Spectrometry Imaging of Liposomal Doxorubicin Delivery and Bilayer Fate in Three-Dimensional Tumor Models.
Lopez A; Holbrook JH; Kemper GE; Lukowski JK; Andrews WT; Hummon AB
Anal Chem; 2024 Jun; 96(22):9254-9261. PubMed ID: 38778440
[TBL] [Abstract][Full Text] [Related]
12. Multibarrier-penetrating drug delivery systems for deep tumor therapy based on synergistic penetration strategy.
Zhang HF; Yu H; Pan SX; Zhang C; Ma YH; Zhang YF; Zuo LL; Hao CY; Lin XY; Geng H; Wu D; Mu SQ; Yu WL; Shi NQ
Biomater Sci; 2024 Apr; 12(9):2321-2330. PubMed ID: 38488841
[TBL] [Abstract][Full Text] [Related]
13. Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy.
Muñoz NM; Williams M; Dixon K; Dupuis C; McWatters A; Avritscher R; Manrique SZ; McHugh K; Murthy R; Tam A; Naing A; Patel SP; Leach D; Hartgerink JD; Young S; Prakash P; Hwu P; Sheth RA
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589526
[TBL] [Abstract][Full Text] [Related]
14. Integrin αvβ3 and LHRH Receptor Double Directed Nano-Analogue Effective Against Ovarian Cancer in Mice Model.
Qi N; Zhou X; Ma N; Zhang J; Wang Z; Zhang X; Li A
Int J Nanomedicine; 2024; 19():3071-3086. PubMed ID: 38562611
[TBL] [Abstract][Full Text] [Related]
15. Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro.
Zhou QH; You YZ; Wu C; Huang Y; Oupický D
J Drug Target; 2009 Jun; 17(5):364-73. PubMed ID: 19263264
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Tumor Targeting and Antitumor Activity of Methylated β-Cyclodextrin-Threaded Polyrotaxanes by Conjugating Cyclic RGD Peptides.
Zhang S; Tamura A; Yui N
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397461
[TBL] [Abstract][Full Text] [Related]
17. Manganese-52: applications in cell radiolabelling and liposomal nanomedicine PET imaging using oxine (8-hydroxyquinoline) as an ionophore.
Gawne P; Man F; Fonslet J; Radia R; Bordoloi J; Cleveland M; Jimenez-Royo P; Gabizon A; Blower PJ; Long N; de Rosales RTM
Dalton Trans; 2018 Jul; 47(28):9283-9293. PubMed ID: 29796500
[TBL] [Abstract][Full Text] [Related]
18. Overcoming the Lack of Oral Availability of Cyclic Hexapeptides: Design of a Selective and Orally Available Ligand for the Integrin αvβ3.
Weinmüller M; Rechenmacher F; Kiran Marelli U; Reichart F; Kapp TG; Räder AFB; Di Leva FS; Marinelli L; Novellino E; Muñoz-Félix JM; Hodivala-Dilke K; Schumacher A; Fanous J; Gilon C; Hoffman A; Kessler H
Angew Chem Int Ed Engl; 2017 Dec; 56(51):16405-16409. PubMed ID: 29072809
[TBL] [Abstract][Full Text] [Related]
19. Regression of Melanoma Following Intravenous Injection of Plumbagin Entrapped in Transferrin-Conjugated, Lipid-Polymer Hybrid Nanoparticles.
Sakpakdeejaroen I; Somani S; Laskar P; Mullin M; Dufès C
Int J Nanomedicine; 2021; 16():2615-2631. PubMed ID: 33854311
[TBL] [Abstract][Full Text] [Related]
20. Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy.
Li Z; Liu C; Li C; Wang F; Liu J; Zheng Z; Wu J; Zhang B
J Nanobiotechnology; 2021 Dec; 19(1):421. PubMed ID: 34906155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
